BofA Securities analyst Bryan Spillane reiterated a Buy rating on the shares of Colgate-Palmolive Company (NYSE:CL) and raised the price target from $90 to $100.
CL opened the year with organic sales growth of +9.8% and high-quality EPS of $0.86 versus the analyst's estimate of $0.82.
Pricing growth of +8.5% exceeded the analyst's forecast by +410 basis points, helping deliver 330 basis points of gross margin expansion that drove the +150 basis points beat vs the analyst's estimates.
Hyperinflation in Argentina, Africa, and the Mid-East was largely responsible for the upside as evidenced by the widest outperformance by segment in ...